Go Pro
NASDAQ:ELAB

PMGC Q1 2026 Earnings Report

PMGC logo
$4.57 +0.05 (+1.11%)
Closing price 09/25/2026 03:59 PM Eastern
Extended Trading
$4.56 -0.02 (-0.33%)
As of 09/25/2026 07:48 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

PMGC EPS Results

Actual EPS
-$112.19
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

PMGC Revenue Results

Actual Revenue
$0.68 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

PMGC Announcement Details

Quarter
Q1 2026
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

PMGC Earnings Headlines

Your book attached
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time through a temporary download link. He plans to charge for it soon. Download your copy now and lock it in at no cost, regardless of future pricing.tc pixel
PMGC Holdings Inc. (ELAB)
See More PMGC Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like PMGC? Sign up for Earnings360's daily newsletter to receive timely earnings updates on PMGC and other key companies, straight to your email.

About PMGC

PMGC (NASDAQ:ELAB) was a special purpose acquisition company that completed a business combination with Elevai Labs, Inc. Following the transaction, the combined company operates under the Elevai Labs name and trades on the Nasdaq under the symbol ELAB.

Elevai Labs is a biotechnology and medical aesthetics company focused on developing and commercializing physician-dispensed skincare and regenerative aesthetic products. Its research and product development activities center on aesthetic treatments designed to support skin health, rejuvenation and post-procedure care.

The company serves the professional aesthetics market through products intended for use by physicians and other qualified medical providers. Elevai Labs is headquartered in California and has focused its commercial activities primarily on the United States. Information about its current leadership and the full scope of its international operations was not available from the information provided.

View PMGC Profile